None listed
Conditions
Interventions
Intervention1: Regime comprising Hair growth serum, hair oil, neutraceuticals: Serum: 1 mL of the serum will be applied on the divided sections of the scalp using a graduated dropper per application a
Sponsors
Tatvartha Health Private Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1.Female Patients aged 18 to 45years with female pattern hair loss 2.Subjects willing to provide written informed consent, indicating that they thoroughly understand the purpose and procedures required for the study and are willing to participate in the study. 3.Patients willing to undergo shaving of a test area on the scalp and have a mark in the target area. 4.Patient s willingness to maintain same hair length. 5.Patients with blood parameters within the normal range as per blood investigations.
Exclusion criteria
Exclusion criteria: 1.Clinically relevant abnormal physical findings which could interfere with the study; in particular, skin damage such as skin abrasion, actinic keratosis or any abnormal findings in the scalp. 2.Clinically significant dandruff. 3.Active unstable thyroid disease, including subjects on therapy for either hyperthyroidism or hypothyroidism unless their dose of thyroid medication has been stable for at least 3 months (self- declared). 4.Patients who had hair transplant surgery or hair weaving. 5.Patient who had light or laser treatment on the scalp. 6.History or evidence of hair loss other than Androgenetic Alopecia (e.g. due to auto-immune, endocrine, mechanical or infectious process or secondary to a scalp dermatological disorder). 7.Patients with active seborrheic dermatitis. 8.Clinically relevant abnormal laboratory values indicative of physical illness (self-declared).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in hair fall, improvement in hair density and improvement in hair quality as per Dermatological assessment, Trichoscan measurement and comb test when compared to placebo, different time points and baseline.Timepoint: Baseline, Month 2, month 4 and month 6. Each timepoint will have 2 visits. | — |
Secondary
| Measure | Time frame |
|---|---|
| change in hair density by dermatological, Trichoscan evaluations, change in hair thickness, hair growth, hair thinning, hair fall by dermatological, instrumental evaluations.Timepoint: Baseline, month 2, month 4, month 6. Each time point will have 2 visits. | — |
Countries
India
Contacts
Public ContactSudhanthiran S
MS Clinical Research Pvt Ltd
Outcome results
None listed